22:44 , Sep 13, 2018 |  BC Week In Review  |  Company News

AI healthcare companies forming an alliance

Artificial intelligence healthcare companies are forming an alliance to advance and guide the use of AI in healthcare and drug development. The Alliance for Artificial Intelligence in Healthcare (AAIH) will act as the industry's advocate...
22:37 , Sep 12, 2018 |  BC Extra  |  Politics & Policy

AI healthcare companies forming an alliance

Artificial intelligence healthcare companies are forming an alliance to advance and guide the use of AI in healthcare and drug development. The Alliance for Artificial Intelligence in Healthcare (AAIH) will act as the industry's advocate...
22:48 , May 3, 2018 |  BC Extra  |  Company News

Management tracks: Achillion, Sangamo

Rare disease company Achillion Pharmaceuticals Inc. (NASDAQ:ACHN) said CEO Milind Deshpande will step down. He will be succeeded by President and COO Joseph Truitt. Sangamo Therapeutics Inc. (NASDAQ:SGMO) said SVP and CBO Curt Herberts, III...
19:36 , Apr 20, 2018 |  Completed Offerings  |  Completed Offerings

BenevolentAI raises $115M

BenevolentAI (London, U.K.) raised $115 million on April 19 in a financing round that drew participation from 50 new and existing investors, including existing investor Woodford Investment Management. Most of the investors were U.S.-based. BenevolentAI’s...
17:40 , Apr 19, 2018 |  BC Extra  |  Financial News

BenevolentAI raises $115M

BenevolentAI (London, U.K.) raised $115 million in a financing round that drew participation from 50 new and existing investors, including existing investor Woodford Investment Management. Most of the investors were U.S.-based. BenevolentAI’s Judgment Augmented Cognition...
00:38 , Mar 7, 2018 |  BC Innovations  |  Translation in Brief

Arcing toward AI

LifeArc announced in January it is tapping into AI capabilities at the University of Cambridge’s Milner Therapeutics Institute through a partnership aimed at identifying and validating new targets for cancer immunotherapy and respiratory disease early...
21:01 , Mar 2, 2018 |  BC Week In Review  |  Company News

BenevolentAI acquires facility at Babraham campus

BenevolentAI (London, U.K.) acquired a drug discovery and development facility on the Babraham Research Campus (Cambridge, U.K.) for an undisclosed amount. The AI company will integrate with a team from the Cambridge campus to use...
23:48 , Aug 22, 2017 |  BC Extra  |  Company News

Management tracks: Akari, Turnstone, Iconic

Autoimmune and inflammatory disease company Akari Therapeutics plc (NASDAQ:AKTX) named David Horn Solomon CEO, effective Aug. 28. He was managing partner at Sund Capital, and was previously CEO of Zealand Pharma A/S (CSE:ZEAL; NASDAQ:ZEAL) and...
22:40 , Jul 14, 2017 |  BC Extra  |  Financial News

AI newco Qrativ raises $8.3M

Artificial intelligence newco Qrativ Holdings LLC (Cambridge, Mass.) launched with $8.3 million in a series A round from Matrix Capital Management, Matrix Partners and the Mayo Clinic . Qrativ was founded this year by Murali...
21:29 , May 4, 2017 |  BC Innovations  |  Tools & Techniques

Testing intelligence

An explosion in access to high-power hardware and deep computer learning has made companies like Atomwise Inc. confident that artificial intelligence (AI) can finally deliver on its decades-old promise to accelerate drug discovery. The company...